www.booki.seOberoende prisjämförelse för böcker
© 2026 Booki – CA Advertising AB (org.nr 556869-1520). Alla rättigheter förbehållna.
Prisbevakning
Få notis vid prissänkningLägsta pris
Vi har hittat boken hos 2 butiker med verifierade priser — alla är partnerbutiker som vi får provision från när du klickar på ”Visa hos butik”. Vissa butiker visas som extern länk utan pris — priset ser du först hos butiken. Priset för dig är detsamma. Frakt kan tillkomma och varierar mellan butiker och leveranssätt — kontrollera alltid aktuellt pris och leveransvillkor hos butiken innan du slutför köpet.
Skriver du om boken på en blogg eller sajt? .
Priset har nyligen gått ner jämfört med butikens eget tidigare pris.
Det lägsta priset vi sett för boken sedan Booki började mäta.
Billigaste butiken ligger under de övriga butikernas medianpris just nu — en jämförelse mellan butiker, inte ett prisfall över tid.
Butiken med lägst pris i prislistan på boksidan just nu.
Pharmacological Targets in Metabolic Diseases: Challenges and Opportunities is a complete reference on possible drug development targets to be leveraged in therapeutic developments. Covering both signaling pathways and specific proteins, the book presents ways to modulate the molecular and cellular alterations observed in metabolic diseases and disorders through the application of new or classical drugs. The comprehensive coverage starts by providing an overview of metabolic diseases and disorders, biological alterations, and pharmacological targets. This section covers targets at both molecular, and subcellular and cellular levels. The next section in the book is focused on pharmaceutical targeting of organs, including a dedicated chapter to the gut-brain axis. Next comes a thorough review of the current advances in metabolic syndrome research. Section VI is focused on inborn errors of metabolism and is followed by a section devoted to natural molecules and their pharmacological potential to treat these conditions. The Editor introduces next a whole section dedicated to the role of the microbiota in metabolic diseases therapeutics. The following sections cover the impact of aging, nanotechnology, the environment, and finally diagnostic techniques in metabolic diseases and disorders. Pharmacological Targets in Metabolic Diseases: Challenges and Opportunities meet the needs of pharmacology researchers looking for a comprehensive and authoritative source of information on possible therapeutic targets to treat these conditions. Research physicians, nutritionists, pharmacists, and biologists can benefit from the detailed information provided at the different levels of targets identified to treat metabolic diseases and conditions.Covers the most prevalent metabolic diseases and disorders such as metabolic syndrome, diabetes mellitus (types I and II) and dyslipidemia, among othersIncludes chapters on the microbiome and environmental pollution as they relate to metabolic diseases and conditionsDiscusses cellular structures like the endoplasmic reticulum and mitochondria as pharmacological targets
Bra läge att köpa
Bokus
265 kr billigare
Rör sig ofta
Författare
Marcos Roberto de Oliveira
Förlag
Elsevier Science & Technology
Utgivningsår
2025
Språk
Engelska
ISBN
9780443273704
Av: Marcos Roberto de Oliveira
Lägsta pris
Vi har hittat boken hos 2 butiker med verifierade priser — alla är partnerbutiker som vi får provision från när du klickar på ”Visa hos butik”. Vissa butiker visas som extern länk utan pris — priset ser du först hos butiken. Priset för dig är detsamma. Frakt kan tillkomma och varierar mellan butiker och leveranssätt — kontrollera alltid aktuellt pris och leveransvillkor hos butiken innan du slutför köpet.
Skriver du om boken på en blogg eller sajt? .
Priset har nyligen gått ner jämfört med butikens eget tidigare pris.
Det lägsta priset vi sett för boken sedan Booki började mäta.
Billigaste butiken ligger under de övriga butikernas medianpris just nu — en jämförelse mellan butiker, inte ett prisfall över tid.
Butiken med lägst pris i prislistan på boksidan just nu.
Pharmacological Targets in Metabolic Diseases: Challenges and Opportunities is a complete reference on possible drug development targets to be leveraged in therapeutic developments. Covering both signaling pathways and specific proteins, the book presents ways to modulate the molecular and cellular alterations observed in metabolic diseases and disorders through the application of new or classical drugs. The comprehensive coverage starts by providing an overview of metabolic diseases and disorders, biological alterations, and pharmacological targets. This section covers targets at both molecular, and subcellular and cellular levels. The next section in the book is focused on pharmaceutical targeting of organs, including a dedicated chapter to the gut-brain axis. Next comes a thorough review of the current advances in metabolic syndrome research. Section VI is focused on inborn errors of metabolism and is followed by a section devoted to natural molecules and their pharmacological potential to treat these conditions. The Editor introduces next a whole section dedicated to the role of the microbiota in metabolic diseases therapeutics. The following sections cover the impact of aging, nanotechnology, the environment, and finally diagnostic techniques in metabolic diseases and disorders. Pharmacological Targets in Metabolic Diseases: Challenges and Opportunities meet the needs of pharmacology researchers looking for a comprehensive and authoritative source of information on possible therapeutic targets to treat these conditions. Research physicians, nutritionists, pharmacists, and biologists can benefit from the detailed information provided at the different levels of targets identified to treat metabolic diseases and conditions.Covers the most prevalent metabolic diseases and disorders such as metabolic syndrome, diabetes mellitus (types I and II) and dyslipidemia, among othersIncludes chapters on the microbiome and environmental pollution as they relate to metabolic diseases and conditionsDiscusses cellular structures like the endoplasmic reticulum and mitochondria as pharmacological targets
Bra läge att köpa
Bokus
265 kr billigare
Rör sig ofta
Författare
Marcos Roberto de Oliveira
Förlag
Elsevier Science & Technology
Utgivningsår
2025
Språk
Engelska
ISBN
9780443273704
Engelska
”23% billigare” visar hur mycket lägre det billigaste priset är än medianpriset hos de övriga butikerna just nu — inte ett tidsbegränsat prisfall.
ISBN 9780443273704 jämförs hos alla butiker
Pharmacological Targets in Metabolic Diseases: Challenges and Opportunities is a complete reference on possible drug development targets to be leveraged in therapeutic developments. Covering both signaling pathways and specific proteins, the book presents ways to modulate the molecular and cellular alterations observed in metabolic diseases and disorders through the application of new or classical drugs. The comprehensive coverage starts by providing an overview of metabolic diseases and disorders, biological alterations, and pharmacological targets. This section covers targets at both molecular, and subcellular and cellular levels. The next section in the book is focused on pharmaceutical targeting of organs, including a dedicated chapter to the gut-brain axis. Next comes a thorough review of the current advances in metabolic syndrome research. Section VI is focused on inborn errors of metabolism and is followed by a section devoted to natural molecules and their pharmacological potential to treat these conditions. The Editor introduces next a whole section dedicated to the role of the microbiota in metabolic diseases therapeutics. The following sections cover the impact of aging, nanotechnology, the environment, and finally diagnostic techniques in metabolic diseases and disorders. Pharmacological Targets in Metabolic Diseases: Challenges and Opportunities meet the needs of pharmacology researchers looking for a comprehensive and authoritative source of information on possible therapeutic targets to treat these conditions. Research physicians, nutritionists, pharmacists, and biologists can benefit from the detailed information provided at the different levels of targets identified to treat metabolic diseases and conditions.Covers the most prevalent metabolic diseases and disorders such as metabolic syndrome, diabetes mellitus (types I and II) and dyslipidemia, among othersIncludes chapters on the microbiome and environmental pollution as they relate to metabolic diseases and conditionsDiscusses cellular structures like the endoplasmic reticulum and mitochondria as pharmacological targets
Bra läge att köpa
Bokus
265 kr billigare
Rör sig ofta
Författare
Marcos Roberto de Oliveira
Förlag
Elsevier Science & Technology
Språk
Engelska
ISBN
9780443273704
Det lägsta priset just nu är 2099 kr hos Bokus, av 2 butiker vi jämför. Priser ändras löpande – kontrollera alltid slutpris och frakt hos butiken innan köp.
Priserna uppdateras automatiskt, vanligtvis minst en gång per dygn. Senaste registrerade uppdatering: 8 juli 2026.
Varje butik sätter sitt eget pris och kör olika kampanjer, så samma bok kan kosta olika mycket. Sverige har fri prissättning på böcker – därför lönar det sig att jämföra, och här ser du priserna samlade på ett ställe.
Nej. Priset vi visar är butikens bokpris – fraktkostnad tillkommer och varierar mellan butiker (flera erbjuder fri frakt över en viss summa). Den slutliga fraktkostnaden ser du i butikens kassa innan du betalar.
Ja. Sätt en kostnadsfri prisbevakning så får du besked när priset faller. Du kan också följa prisutvecklingen i prishistoriken här på sidan.
Mer om butikerna
Läs om frakt, betalning, retur och omdömen för butikerna vi jämför priser hos.
